Out of Agonists Comes an Antagonist

Frontlines | Out of Agonists Comes an Antagonist Reprinted with permission from Nature Pseudomonas aeruginosa can devastate the lungs of a person with cystic fibrosis or a suppressed immune system, for these bacteria are more than the sum of their parts. When their numbers reach a critical mass, signaling from accumulated microbial "autoinducers" triggers production of virulence factors and formation of a biofilm, a polysaccharide shield that protects the bacterial colony from an immune re

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Pseudomonas aeruginosa can devastate the lungs of a person with cystic fibrosis or a suppressed immune system, for these bacteria are more than the sum of their parts. When their numbers reach a critical mass, signaling from accumulated microbial "autoinducers" triggers production of virulence factors and formation of a biofilm, a polysaccharide shield that protects the bacterial colony from an immune response and antibiotics. "Underneath the protective biofilm, the cells are happily reproducing, damaging the tissue and producing toxins," says Hiroaki Suga, associate professor of chemistry at the State University of New York at Buffalo.

By synthesizing a library of compounds that interact with P. aeruginosa's autoinducer (N-acyl-homoserine lactone), Suga and his colleagues discovered a compound that blocks biofilm formation--suggesting a novel and powerful antibiotic approach by blocking the communication, called quorum sensing (K.M. Smith et al., "Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs," Chem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ricki Lewis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours